1. Helmholtz Zentrum München, Gauting, Germany;
2. Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom;
3. Université de Montréal, Centre Hospitalier de l'Universite de Montreal (CHUM), and Inserm Unit 743, Montreal, QC;
4. Macfarlane Burnet Institute for Medical Research, Melbourne, Australia;
5. Centre d'Immunologie de Marseille-Luminy (CIML), Université de la Méditerranée, Marseille, France;
6. Inserm U631, Marseille, France;
7. Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 6102, Marseille, France;
8. Laboratory of Experimental Surgery, Department of General and Thoracic Surgery, University of Giessen, Giessen, Germany;
9. Anzac Research Institute, Sydney, Australia;
10. Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands;
11. Department of Immunology, University of Texas, M. D. Anderson Cancer Center, Houston, TX;
12. Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom;
13. Mount Sinai School of Medicine, New York, NY;
14. Klinik für Nephrologie und Klinische Immunologie, Municipal Hospital Harlaching, Ludwig-Maximilians-University, Muenchen, Germany;
15. Department of Research and Development, Miltenyi Biotec, Bergisch Gladbach, Germany;
16. The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia;
17. Department of Biomedical Sciences and Biotechnology, University of Brescia, Brescia, Italy;
18. Institute of Immunology, Medical University Vienna, Wien, Austria;
19. Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Krakow, Poland;
20. Nuffield Department of Surgery, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom; and
21. Institute for Virology and Immunobiology, University of Wuerzburg, Wuerzburg, Germany